Industry Research Reports
Home > Reports > Pharma & Healthcare > Human Prothrombin Complex- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Human Prothrombin Complex- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Industry: Pharma & Healthcare
Published Date: 2026-01-04
Pages: 100 Pages
Report ld: 5495135
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Human Prothrombin Complex Market Size(US$)
CAGR 2026-2032
11.8%
Market Size,2032
USD 4,702
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 2,408 million
Market Forecast in 2032(Value)
US$ 4,702 million
CAGR
11.8%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Human Prothrombin Complex was estimated to be worth US$ 2177 million in 2025 and is projected to reach US$ 4702 million, growing at a CAGR of 11.8% from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Human Prothrombin Complex cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Global Human Prothrombin Complex key players include Octapharma, Shire, CSL, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 45%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.
In terms of product, 500 IU/Vial is the largest segment, with a share over 50%. And in terms of application, the largest application is Hemophilia B, followed by Vitamin K Deficiency, etc.
This report provides a comprehensive view of the global market for Human Prothrombin Complex, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Human Prothrombin Complex market size, estimations, and forecasts are presented in terms of sales volume (K Units) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Human Prothrombin Complex.
MARKET SEGMENTATION
By Company
- Takeda
- CSL
- Grifols
- Octapharma
- Hualan Biological
- Meheco Xinxing Pharma
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- 500 IU/Vial
- 600 IU/Vial
- 1000 IU/Vial
- Others
Segment by Application
- Hemophilia B
- Vitamin K Deficiency
- Others
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Human Prothrombin Complex manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Human Prothrombin Complex sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Human Prothrombin Complex sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Human Prothrombin Complex Product Introduction
1.2 Global Human Prothrombin Complex Market Size Forecast
1.2.1 Global Human Prothrombin Complex Sales Value (2021–2032)
1.2.2 Global Human Prothrombin Complex Sales Volume (2021–2032)
1.2.3 Global Human Prothrombin Complex Sales Price (2021–2032)
1.3 Human Prothrombin Complex Market Trends & Drivers
1.3.1 Human Prothrombin Complex Industry Trends
1.3.2 Human Prothrombin Complex Market Drivers & Opportunities
1.3.3 Human Prothrombin Complex Market Challenges
1.3.4 Human Prothrombin Complex Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Human Prothrombin Complex Players Revenue Ranking (2025)
2.2 Global Human Prothrombin Complex Revenue by Company (2021–2026)
2.3 Global Human Prothrombin Complex Sales Volume Ranking of Players (2025)
2.4 Global Human Prothrombin Complex Sales Volume by Company (2021–2026)
2.5 Global Human Prothrombin Complex Average Price by Company (2021–2026)
2.6 Key Manufacturers Human Prothrombin Complex Manufacturing Base and Headquarters
2.7 Key Manufacturers Human Prothrombin Complex Product Offerings
2.8 Key Manufacturers Start of Mass Production of Human Prothrombin Complex
2.9 Human Prothrombin Complex Market Competitive Analysis
2.9.1 Human Prothrombin Complex Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Human Prothrombin Complex Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Human Prothrombin Complex revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Human Prothrombin Complex Market Classification
3.1 Introduction by Type
3.1.1 500 IU/Vial
3.1.2 600 IU/Vial
3.1.3 1000 IU/Vial
3.1.4 Others
3.1.5 Global Human Prothrombin Complex Sales Value by Type
3.1.5.1 Global Human Prothrombin Complex Sales Value by Type (2021 vs 2025 vs 2032)
3.1.5.2 Global Human Prothrombin Complex Sales Value, by Type (2021–2032)
3.1.5.3 Global Human Prothrombin Complex Sales Value, by Type (%), 2021–2032
3.1.6 Global Human Prothrombin Complex Sales Volume by Type
3.1.6.1 Global Human Prothrombin Complex Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.6.2 Global Human Prothrombin Complex Sales Volume, by Type (2021–2032)
3.1.6.3 Global Human Prothrombin Complex Sales Volume, by Type (%), 2021–2032
3.1.7 Global Human Prothrombin Complex Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hemophilia B
4.1.2 Vitamin K Deficiency
4.1.3 Others
4.2 Global Human Prothrombin Complex Sales Value by Application
4.2.1 Global Human Prothrombin Complex Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Human Prothrombin Complex Sales Value, by Application (2021–2032)
4.2.3 Global Human Prothrombin Complex Sales Value, by Application (%), 2021–2032
4.3 Global Human Prothrombin Complex Sales Volume by Application
4.3.1 Global Human Prothrombin Complex Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Human Prothrombin Complex Sales Volume, by Application (2021–2032)
4.3.3 Global Human Prothrombin Complex Sales Volume, by Application (%), 2021–2032
4.4 Global Human Prothrombin Complex Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Human Prothrombin Complex Sales Value by Region
5.1.1 Global Human Prothrombin Complex Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Human Prothrombin Complex Sales Value by Region (2021–2026)
5.1.3 Global Human Prothrombin Complex Sales Value by Region (2027–2032)
5.1.4 Global Human Prothrombin Complex Sales Value by Region (%), 2021–2032
5.2 Global Human Prothrombin Complex Sales Volume by Region
5.2.1 Global Human Prothrombin Complex Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Human Prothrombin Complex Sales Volume by Region (2021–2026)
5.2.3 Global Human Prothrombin Complex Sales Volume by Region (2027–2032)
5.2.4 Global Human Prothrombin Complex Sales Volume by Region (%), 2021–2032
5.3 Global Human Prothrombin Complex Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Human Prothrombin Complex Sales Value, 2021–2032
5.4.2 North America Human Prothrombin Complex Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Human Prothrombin Complex Sales Value, 2021–2032
5.5.2 Europe Human Prothrombin Complex Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Human Prothrombin Complex Sales Value, 2021–2032
5.6.2 Asia Pacific Human Prothrombin Complex Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Human Prothrombin Complex Sales Value, 2021–2032
5.7.2 South America Human Prothrombin Complex Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Human Prothrombin Complex Sales Value, 2021–2032
5.8.2 Middle East & Africa Human Prothrombin Complex Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Human Prothrombin Complex Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Human Prothrombin Complex Sales Value and Sales Volume
6.2.1 Key Countries/Regions Human Prothrombin Complex Sales Value, 2021–2032
6.2.2 Key Countries/Regions Human Prothrombin Complex Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Human Prothrombin Complex Sales Value, 2021–2032
6.3.2 United States Human Prothrombin Complex Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Human Prothrombin Complex Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Human Prothrombin Complex Sales Value, 2021–2032
6.4.2 Europe Human Prothrombin Complex Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Human Prothrombin Complex Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Human Prothrombin Complex Sales Value, 2021–2032
6.5.2 China Human Prothrombin Complex Sales Value by Type (%), 2025 vs 2032
6.5.3 China Human Prothrombin Complex Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Human Prothrombin Complex Sales Value, 2021–2032
6.6.2 Japan Human Prothrombin Complex Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Human Prothrombin Complex Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Human Prothrombin Complex Sales Value, 2021–2032
6.7.2 South Korea Human Prothrombin Complex Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Human Prothrombin Complex Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Human Prothrombin Complex Sales Value, 2021–2032
6.8.2 Southeast Asia Human Prothrombin Complex Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Human Prothrombin Complex Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Human Prothrombin Complex Sales Value, 2021–2032
6.9.2 India Human Prothrombin Complex Sales Value by Type (%), 2025 vs 2032
6.9.3 India Human Prothrombin Complex Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Takeda
7.1.1 Takeda Company Information
7.1.2 Takeda Introduction and Business Overview
7.1.3 Takeda Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 Takeda Human Prothrombin Complex Product Offerings
7.1.5 Takeda Recent Developments
7.2 CSL
7.2.1 CSL Company Information
7.2.2 CSL Introduction and Business Overview
7.2.3 CSL Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 CSL Human Prothrombin Complex Product Offerings
7.2.5 CSL Recent Developments
7.3 Grifols
7.3.1 Grifols Company Information
7.3.2 Grifols Introduction and Business Overview
7.3.3 Grifols Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Grifols Human Prothrombin Complex Product Offerings
7.3.5 Grifols Recent Developments
7.4 Octapharma
7.4.1 Octapharma Company Information
7.4.2 Octapharma Introduction and Business Overview
7.4.3 Octapharma Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Octapharma Human Prothrombin Complex Product Offerings
7.4.5 Octapharma Recent Developments
7.5 Hualan Biological
7.5.1 Hualan Biological Company Information
7.5.2 Hualan Biological Introduction and Business Overview
7.5.3 Hualan Biological Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 Hualan Biological Human Prothrombin Complex Product Offerings
7.5.5 Hualan Biological Recent Developments
7.6 Meheco Xinxing Pharma
7.6.1 Meheco Xinxing Pharma Company Information
7.6.2 Meheco Xinxing Pharma Introduction and Business Overview
7.6.3 Meheco Xinxing Pharma Human Prothrombin Complex Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 Meheco Xinxing Pharma Human Prothrombin Complex Product Offerings
7.6.5 Meheco Xinxing Pharma Recent Developments
8 Industry Chain Analysis
8.1 Human Prothrombin Complex Industrial Chain
8.2 Human Prothrombin Complex Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Human Prothrombin Complex Sales Model
8.5.2 Sales Channels
8.5.3 Human Prothrombin Complex Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Human Prothrombin Complex Market Trends
Table 2. Human Prothrombin Complex Market Drivers & Opportunities
Table 3. Human Prothrombin Complex Market Challenges
Table 4. Human Prothrombin Complex Market Restraints
List of Figures
Figure 1. Human Prothrombin Complex Product Picture
Figure 2. Global Human Prothrombin Complex Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Global Human Prothrombin Complex Sales Value (US$ Million), 2021–2032
Figure 4. Global Human Prothrombin Complex Sales Volume (K Units), 2021–2032
Figure 5. Global Human Prothrombin Complex Sales Price (M USD/Unit), 2021–2032
Figure 6. Human Prothrombin Complex Report Years Considered
Figure 7. Global Human Prothrombin Complex Players Revenue Ranking (US$ Million), 2025
Figure 8. Global Human Prothrombin Complex Sales Volume Ranking of Players (K Units), 2025
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Human Prothrombin Complex Revenue in 2025
Figure 10. Human Prothrombin Complex Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 11. 500 IU/Vial Picture
Figure 12. 600 IU/Vial Picture
Figure 13. 1000 IU/Vial Picture
Figure 14. Others Picture
Figure 15. Global Human Prothrombin Complex Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
Figure 16. Global Human Prothrombin Complex Sales Value Market Share by Type, 2025 & 2032
Figure 17. Global Human Prothrombin Complex Sales Volume by Type (K Units), 2021 vs 2025 vs 2032
Figure 18. Global Human Prothrombin Complex Sales Volume Market Share by Type, 2025 & 2032
Figure 19. Global Human Prothrombin Complex Price by Type (M USD/Unit), 2021–2032
Figure 20. Product Picture of Hemophilia B
Figure 21. Product Picture of Vitamin K Deficiency
Figure 22. Product Picture of Others
Figure 23. Global Human Prothrombin Complex Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
Figure 24. Global Human Prothrombin Complex Sales Value Market Share by Application, 2025 & 2032
Figure 25. Global Human Prothrombin Complex Sales Volume by Application (K Units), 2021 vs 2025 vs 2032
Figure 26. Global Human Prothrombin Complex Sales Volume Market Share by Application, 2025 & 2032
Figure 27. Global Human Prothrombin Complex Price by Application (M USD/Unit), 2021–2032
Figure 28. North America Human Prothrombin Complex Sales Value (US$ Million), 2021–2032
Figure 29. North America Human Prothrombin Complex Sales Value by Country (%), 2025 vs 2032
Figure 30. Europe Human Prothrombin Complex Sales Value (US$ Million), 2021–2032
Figure 31. Europe Human Prothrombin Complex Sales Value by Country (%), 2025 vs 2032
Figure 32. Asia Pacific Human Prothrombin Complex Sales Value (US$ Million), 2021–2032
Figure 33. Asia Pacific Human Prothrombin Complex Sales Value by Region (%), 2025 vs 2032
Figure 34. South America Human Prothrombin Complex Sales Value (US$ Million), 2021–2032
Figure 35. South America Human Prothrombin Complex Sales Value by Country (%), 2025 vs 2032
Figure 36. Middle East & Africa Human Prothrombin Complex Sales Value (US$ Million), 2021–2032
Figure 37. Middle East & Africa Human Prothrombin Complex Sales Value by Country (%), 2025 vs 2032
Figure 38. Key Countries/Regions Human Prothrombin Complex Sales Value (%), 2021–2032
Figure 39. Key Countries/Regions Human Prothrombin Complex Sales Volume (%), 2021–2032
Figure 40. United States Human Prothrombin Complex Sales Value (US$ Million), 2021–2032
Figure 41. United States Human Prothrombin Complex Sales Value by Type (%), 2025 vs 2032
Figure 42. United States Human Prothrombin Complex Sales Value by Application (%), 2025 vs 2032
Figure 43. Europe Human Prothrombin Complex Sales Value (US$ Million), 2021–2032
Figure 44. Europe Human Prothrombin Complex Sales Value by Type (%), 2025 vs 2032
Figure 45. Europe Human Prothrombin Complex Sales Value by Application (%), 2025 vs 2032
Figure 46. China Human Prothrombin Complex Sales Value (US$ Million), 2021–2032
Figure 47. China Human Prothrombin Complex Sales Value by Type (%), 2025 vs 2032
Figure 48. China Human Prothrombin Complex Sales Value by Application (%), 2025 vs 2032
Figure 49. Japan Human Prothrombin Complex Sales Value (US$ Million), 2021–2032
Figure 50. Japan Human Prothrombin Complex Sales Value by Type (%), 2025 vs 2032
Figure 51. Japan Human Prothrombin Complex Sales Value by Application (%), 2025 vs 2032
Figure 52. South Korea Human Prothrombin Complex Sales Value (US$ Million), 2021–2032
Figure 53. South Korea Human Prothrombin Complex Sales Value by Type (%), 2025 vs 2032
Figure 54. South Korea Human Prothrombin Complex Sales Value by Application (%), 2025 vs 2032
Figure 55. Southeast Asia Human Prothrombin Complex Sales Value (US$ Million), 2021–2032
Figure 56. Southeast Asia Human Prothrombin Complex Sales Value by Type (%), 2025 vs 2032
Figure 57. Southeast Asia Human Prothrombin Complex Sales Value by Application (%), 2025 vs 2032
Figure 58. India Human Prothrombin Complex Sales Value (US$ Million), 2021–2032
Figure 59. India Human Prothrombin Complex Sales Value by Type (%), 2025 vs 2032
Figure 60. India Human Prothrombin Complex Sales Value by Application (%), 2025 vs 2032
Figure 61. Human Prothrombin Complex Industrial Chain
Figure 62. Human Prothrombin Complex Manufacturing Cost Structure
Figure 63. Channels of Distribution (Direct Sales, and Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which region is expected to have the highest market share?
For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 11.8% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.
What is the annual compound growth rate of the global Human Prothrombin Complex market size from 2026 to 2032?
Which companies rank high in the global Human Prothrombin Complex market?
What was the global market size of Human Prothrombin Complex in 2032?
What was the global market size of Human Prothrombin Complex in 2026?
Related Reports
Global Human Prothrombin Complex Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Human Prothrombin Complex market size was US$ 2177 million in 2025 and is forecast to reach a readjusted size of US$ 4702 million by 2032 with a CAGR of 11.8% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 80
USD 4250.00
(Single User License)
Global Human Prothrombin Complex Market Research Report 2026
The global Human Prothrombin Complex market was valued at US$ 2177 million in 2025 and is anticipated to reach US$ 4702 million by 2032, at a CAGR of 11.8% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 117
USD 2900.00
(Single User License)
Global Human Prothrombin Complex Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Human Prothrombin Complex market is projected to grow from US$ 1968 million in 2024 to US$ 4251 million by 2031, at a CAGR of 11.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 146
USD 4900.00
(Single User License)
Global Human Prothrombin Complex Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Human Prothrombin Complex was estimated to be worth US$ 1968 million and is forecast to reach approximately US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 139
USD 5900.00
(Single User License)
Global Human Prothrombin Complex Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Human Prothrombin Complex market size was US$ 1968 million in 2024 and is forecast to a readjusted size of US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 80
USD 4250.00
(Single User License)
Human Prothrombin Complex- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Human Prothrombin Complex was estimated to be worth US$ 1968 million in 2024 and is forecast to a readjusted size of US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 100
USD 3950.00
(Single User License)
Global Human Prothrombin Complex Market Research Report 2025
The global market for Human Prothrombin Complex was valued at US$ 1968 million in the year 2024 and is projected to reach a revised size of US$ 4251 million by 2031, growing at a CAGR of 11.8% during the forecast period.
Published Date: 2025-01-16
Pages: 86
USD 2900.00
(Single User License)
Global Human Prothrombin Complex Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published Date: 2024-04-17
Pages: 142
USD 5600.00
(Single User License)
Global Human Prothrombin Complex Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published Date: 2024-04-16
Pages: 137
USD 5900.00
(Single User License)
Global Human Prothrombin Complex Market Insights, Forecast to 2030
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published Date: 2024-04-07
Pages: 90
USD 4900.00
(Single User License)
Global Human Prothrombin Complex Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Human Prothrombin Complex market size was US$ 2177 million in 2025 and is forecast to reach a readjusted size of US$ 4702 million by 2032 with a CAGR of 11.8% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 80
USD 4250.00 (Single User License)Global Human Prothrombin Complex Market Research Report 2026
The global Human Prothrombin Complex market was valued at US$ 2177 million in 2025 and is anticipated to reach US$ 4702 million by 2032, at a CAGR of 11.8% from 2026 to 2032.
Published: 2026-01-04
Pages: 117
USD 2900.00 (Single User License)Global Human Prothrombin Complex Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Human Prothrombin Complex market is projected to grow from US$ 1968 million in 2024 to US$ 4251 million by 2031, at a CAGR of 11.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 146
USD 4900.00 (Single User License)Global Human Prothrombin Complex Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Human Prothrombin Complex was estimated to be worth US$ 1968 million and is forecast to reach approximately US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 139
USD 5900.00 (Single User License)Global Human Prothrombin Complex Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Human Prothrombin Complex market size was US$ 1968 million in 2024 and is forecast to a readjusted size of US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 80
USD 4250.00 (Single User License)Human Prothrombin Complex- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Human Prothrombin Complex was estimated to be worth US$ 1968 million in 2024 and is forecast to a readjusted size of US$ 4251 million by 2031 with a CAGR of 11.8% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 100
USD 3950.00 (Single User License)Global Human Prothrombin Complex Market Research Report 2025
The global market for Human Prothrombin Complex was valued at US$ 1968 million in the year 2024 and is projected to reach a revised size of US$ 4251 million by 2031, growing at a CAGR of 11.8% during the forecast period.
Published: 2025-01-16
Pages: 86
USD 2900.00 (Single User License)Global Human Prothrombin Complex Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published: 2024-04-17
Pages: 142
USD 5600.00 (Single User License)Global Human Prothrombin Complex Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published: 2024-04-16
Pages: 137
USD 5900.00 (Single User License)Global Human Prothrombin Complex Market Insights, Forecast to 2030
Prothrombin complex concentrate (PCC), also known as factor IX complex, is a medication made up of blood clotting factors II, IX, and X. Some versions also contain factor VII. It is used to treat and prevent bleeding in hemophilia B if pure factor IX is not available.
Published: 2024-04-07
Pages: 90
USD 4900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now